Alliander NV (NUZ3) Chart

Hive Digital Technologies Executive Chairman Frank Holmes joined Steve Darling from Proactive to share a major operational milestone and the company’s March 2025 production results. HIVE has officially begun mining operations at its new 200-megawatt hydro-powered facility in Yguazú, Paraguay. Phase 1 of the site is now energized and operating at an initial production rate of 100 Petahash. The site is expected to scale steadily in the coming months with additional mining capacity set to be deployed in phases. Holmes also announced that HIVE mined 108 Bitcoin during the month of March, increasing the company’s HODL balance to 2,201 BTC, valued at approximately $180 million based on a Bitcoin price of $82,000 as of March 31, 2025. The company saw an average hashrate of 6.3 Exahash per second, fleet efficiency of 20.7 joules per terahash, peak BTC-only hashrate of 6.2 EH/s and BTC-equivalent hashrate of 6.4 EH/s. The launch of operations in Paraguay reflects HIVE’s continued commitment to expanding its global footprint using green energy solutions. The company views the hydro-powered site as a strategic asset that supports long-term growth and sustainability in Bitcoin mining. #proactiveinvestors #hivedigitaltechnologieslet #tsxv #hive #nasdaq #hive #HiveDigitalTechnologies #FrankHolmes #CryptoNews #Blockchain #AIandCrypto #ParaguayMining #GreenEnergy #BuzzMiner #BitcoinUpdate #DigitalAssets #GPUmining #CryptoExpansion

Optima Health PLC chief executive Jonathan Thomas talked with Proactive's Stephen Gunnion about the company's acquisition of Ireland-based Cognate Health. This deal marks Optima Health’s first foray outside the UK and is aligned with its strategy to supplement organic growth through mergers and acquisitions. Thomas said the move adds around €7 million in revenue and approximately £1 million in EBITDA to the group. Cognate Health is described as a strong platform with 30 clinic facilities across Ireland and around 60 experienced personnel, along with a network of clinicians. According to Thomas, “It’s a really great platform… in addition to obviously the financial aspects… really great opportunities to collaborate, revenue synergies and grow the businesses collectively.” He explained that expanding into a new regulated market provides access to multinational clients seeking services across both the UK and Ireland. The acquisition allows Optima Health to tailor services across jurisdictions while opening up new cross-sell opportunities. Thomas added that the company expects to announce more acquisitions during the year, with several discussions currently underway. Visit Proactive’s YouTube channel for more in-depth business updates and interviews. Don’t forget to give the video a like, subscribe to the channel, and enable notifications so you never miss a story. #OptimaHealth #CognateHealth #HealthcareAcquisition #MergersAndAcquisitions #JonathanThomas #OccupationalHealth #WorkplaceWellbeing #IrelandHealthcare #BusinessExpansion #ProactiveInvestors

Solvonis Therapeutics PLC CEO Anthony Tennyson talked with Proactive's Stephen Gunnion about the company's transformation and its strategy moving into 2025. Tennyson explained that the company, formerly known as Graft Polymer, exited its industrial plastics business in 2024 to focus entirely on biotechnology, particularly mental health and addiction treatments. "These are segments which have large addressable markets, poor current standards of care and therefore significant unmet medical needs," he said. He outlined how the company raised £1.8 million in mid-2024 to support its new growth strategy, which includes partnerships, joint ventures, and acquisitions. A central part of this strategy is the pending acquisition of Awakn Life Sciences, a clinical-stage biotech company focused on alcohol use disorder (AUD) and PTSD. Solvonis is acquiring Awakn in an all-paper deal valued between £3 million and £5 million. Tennyson said this represented significant value, highlighting that similar assets could command substantially higher valuations. Awakn’s AWKN-001, targeting severe AUD, is in phase 3 trials in the UK and EU. AWKN-002, for the US market, has received FDA support for a faster 505(b)(2) development pathway, allowing the use of Johnson & Johnson’s SPRAVATO® data to accelerate progress. Tennyson said the top priority for 2025 is closing and integrating the acquisition and executing on the clinical programs. He emphasised plans to file for FDA approval of a phase 2B trial and to continue to work with Awakn's existing UK partners. Visit Proactive's YouTube channel for more updates like this. Don’t forget to like the video, subscribe to the channel, and enable notifications for future content. #Solvonis #BiotechNews #MentalHealthTreatment #AddictionRecovery #PTSDResearch #AlcoholUseDisorder #PharmaInvesting #AwaknAcquisition #ClinicalTrials #HealthcareInnovation

Petro-Victory Energy Corp CEO Richard Gonzalez joined Steve Darling from Proactive to share key strategic milestones, including new partnerships and acquisitions to strengthen the company’s position in Brazil’s onshore oil and gas sector. The company has entered a strategic partnership with BlueOak Investments to establish a special purpose vehicle (SPV) dedicated to acquiring and developing oil and gas assets across Brazil and Latin America. This partnership combines BlueOak’s financial expertise with Petro-Victory’s operational capabilities to drive sustainable growth. Additionally, Petro-Victory has signed a development agreement with Eneva, one of Brazil’s largest energy operators, securing fully funded commitments for well drilling and seismic exploration. The company also entered a joint venture with ATP, which includes the fully funded drilling of two in-field development wells at the Andorinha Field, along with an option for ATP to acquire interests in Petro-Victory’s assets at pre-determined pricing. The company further expanded its portfolio by acquiring 13 oil-producing fields from Brava Energia S.A., located near existing Petro-Victory concessions. Gonzales reiterated confidence in the company’s long-term strategy, stating, “We have a five-year plan… and we’re very excited about 2025, 2026 and beyond.” Looking ahead, the company’s development plan includes: • A fully funded workover and drilling campaign in the Espirito Santo Basin in 2025. • Full carry on two in-field development wells in the Portiguar Basin in 2025. • Fully funded 3,000-meter gas well and 3D seismic survey to develop the São João Field in 2026. These strategic initiatives position Petro-Victory for significant growth and expansion in Brazil’s energy sector. #proactiveinvestros #prto-victoryenergycorp #tsxv #vry #OilProduction #BrazilEnergy #BrazilEnergy #EnergyInvesting #NaturalGas #OilProduction #Eneva #ATP #BlueOak #CapixabaEnergia #LagoaParda #EnergyPartnerships #ProactiveInve